SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Beer TM, Myrthue A. Calcitriol in cancer treatment: from the lab to the clinic. Mol Cancer Ther 2004;3:S373S381.
  • 2
    Krishnan AV, Peehl DM, Feldman D. Inhibition of prostate cancer growth by vitamin D: regulation of target gene expression. J Cell Biochem 2003;88:S363S371.
  • 3
    Mentor-Marcel R., Lamartiniere CA, Eltoum IA, Greenberg NM, Elgavish A. Dietary genistein improves survival and reduces expression of os-teopontin in the prostate of transgenic mice with prostatic adenocarcinoma (TRAMP). J Nutr 2005;135:S989S995.
  • 4
    Sarkar FH, Li Y. The role of isoflavones in cancer chemoprevention. Front Biosci 2004;9:S2714S2724.
  • 5
    Trump DL, Hershberger PA, Bernardi RJ, et al. Anti-tumor activity of calcitriol: pre-clinical and clinical studies. J Steroid Biochem Mol Biol 2004;89–90:S519S526.
  • 6
    Moreno J., Krishnan AV, Swami S., Nonn L., Peehl DM, Feldman D. Regulation of prostaglandin metabolism by calcitriol attenuates growth stimulation in prostate cancer cells. Cancer Res 2005;65:S7917S7925.
  • 7
    Barnes S., Peterson TG, Coward L. Rationale for the use of genistein-containing soy matrices in chemoprevention trials for breast and prostate cancer. J Cell Biochem Suppl 1995;22:S181S187.
  • 8
    Messina MJ, Persky V., Setchell KD, Barnes S. Soy intake and cancer risk: a review of the in vitro and in vivo data. Nutr Cancer 1994;21:S113S131.
  • 9
    Rao A., Coan A., Welsh JE, Barclay WW, Koumenis C., Cramer SD. Vitamin D receptor and p21/WAF1 are targets of genistein and 1, 25-dihydroxyvitamin D3 in human prostate cancer cells. Cancer Res 2004;64:S2143S2147.
  • 10
    Xiang H., Schevzov G., Gunning P., Williams HM, Silink M. A comparative study of growth-inhibitory effects of isoflavones and their metabolites on human breast and prostate cancer cell lines. Nutr Cancer 2002;42:S224S232.
  • 11
    Wang J., Eltoum IE, Lamartiniere CA. Genistein che-moprevention of prostate cancer in TRAMP mice. J Carcinogenesis 2007;6:S3.
  • 12
    Beer TM, Lemmon D., Lowe BA, Henner WD. High-dose weekly oral calcitriol in patients with a rising PSA after prostatectomy or radiation for prostate carcinoma. Cancer 2003;97:S1217S1224.
  • 13
    Gross C., Stamey T., Hancock S., Feldman D. Treatment of early recurrent prostate cancer with 1, 25-dihydroxyvitamin D3 (calcitriol). J Urol 1998;159:S2035S2039.
  • 14
    Beer TM, Ryan CW, Venner PM, et al. Double-blinded randomized study of high-dose calcitriol plus docetaxel compared with placebo plus do-cetaxel in androgen-independent prostate cancer: a report from the ASCENT investigators. J Clin Oncol 2007;25:S669S674.
  • 15
    Miller GJ, Stapleton GE, Hedlund TE, Moffat KA. Vitamin D receptor expression, 24-hydroxylase activity, and inhibition of growth by 1alpha, 25-dihy-droxyvitamin D3 in seven human prostatic carcinoma cell lines. Clin Cancer Res 1995;1:S997S1003.
  • 16
    Skowronski RJ, Peehl DM, Feldman D. Vitamin D and prostate cancer: 1, 25 dihydroxyvitamin D3 receptors and actions in human prostate cancer cell lines. Endocrinology 1993;132:S1952S1960.
  • 17
    Ly LH, Zhao XY, Holloway L., Feldman D. Liarozole acts synergistically with 1alpha, 25-dihydroxyvita-min D3 to inhibit growth of DU 145 human prostate cancer cells by blocking 24-hydroxylase activity. Endocrinology 1999;140:S2071S2076.
  • 18
    Peehl DM, Seto E., Hsu JY, Feldman D. Preclinical activity of ketoconazole in combination with calcitriol or the vitamin D analogue EB 1089 in prostate cancer cells. J Urol 2002;168:S1583S1588.
  • 19
    Farhan H., Wahala K., Cross HS. Genistein inhibits vitamin D hydroxylases CYP24 and CYP27B1 expression in prostate cells. J Steroid Biochem Mol Biol 2003;84:S423S429.
  • 20
    Wietzke JA, Welsh J. Phytoestrogen regulation of a Vitamin D3 receptor promoter and 1, 25-dihydroxyvitamin D3 actions in human breast cancer cells. J Steroid Biochem Mol Biol 2003;84:S149S157.
  • 21
    Swami S., Krishnan AV, Peehl DM, Feldman D. Genistein potentiates the growth inhibitory effects of 1, 25-dihydroxyvitamin D(3) in DU145 human prostate cancer cells: role of the direct inhibition of CYP24 enzyme activity. Mol Cell Endocrinol 2005;12:S12.
  • 22
    Rao A., Woodruff RD, Wade WN, Kute TE, Cramer SD. Genistein and vitamin D synergistically inhibit human prostatic epithelial cell growth. J Nutr 2002;132:S3191S3194.